Dr. Tien implants first Omnia System in Oregon

Dr. Tien is the first physician in Oregon, and among one of the first in the United States, to have implanted the Senza®Omnia™ system, a new spinal cord stimulation (SCS) therapy for the treatment of chronic pain.

Spinal cord stimulation involves the delivery of electrical signals to the spinal cord in order to alter pain signals to the brain. The electrical pulses are delivered by small electrodes on leads that are placed near the spinal cord and are connected to a compact, battery-powered generator implanted under the skin during a minimally invasive procedure. SCS is a reversible therapy that has helped hundreds of thousands of people experience relief from chronic pain, most commonly, severe pain in the low back and lower extremities.

Chronic pain is the primary cause of adult disability in the U.S. effecting over 50 million Americans.1  It can significantly interfere with a person’s quality of life and functionality.2 Currently, the condition is largely under-treated and misunderstood. There are many causes of chronic pain, including accidents, injuries, degenerative diseases, prior surgeries, or even the aging process. Spinal Cord Stimulation is a well-established pain treatment that has been used in the U.S. for over 30 years and is proven to provide patients superior relief.

The Omnia system was designed to provide physicians and patients with a comprehensive solution to treat the complex and dynamic nature of chronic pain. As the nature of pain can change over time, vary in intensity, or occur in different parts of the body, Omnia provides the most flexible platform that allows patients to have access to all SCS frequencies and the most waveforms over the long term. Physicians no longer have to choose between traditional SCS therapy or HF10. With Omnia, they get both. The Omnia system battery is designed to last ten or more years, even with continuous 10 kHz settings. Patients can evaluate the therapies available in the Omnia system in a temporary trial before having the device implanted.


  1. Prevalence of Chronic Pain and High-Impact Chronic Pain Among Adults — United States, 2016
  2. https://report.nih.gov/nihfactsheets/viewfactsheet.aspx?csid=57

Omnia, HF10 and the HF10 logo, Nevro and the Nevro logo are trademarks of Nevro Corp.